Targeting RNA binding proteins with small-molecule inhibitors: Advances, challenges, and therapeutic opportunities

RNA-binding proteins (RBPs) constitute central regulators of post-transcriptional gene expression and have been increasingly recognized as critical contributors to the pathogenesis of cancer, neurodegenerative disorders, and autoimmune diseases. However, in contrast to well-established drug targets...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Yuning Shi, Dazhi Feng, Jieya Zhou, Lihua Liu, Xinnan Li, Zhenwei Yuan, Jianbing Wu, Hong Yao
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Elsevier 2026-03-01
Ráidu:	Acta Pharmaceutica Sinica B
Fáttát:	RNA binding proteins Post-transcriptional gene expression Disease Small-molecule modulators High-throughput screening Chemical biology approaches
Liŋkkat:	http://www.sciencedirect.com/science/article/pii/S2211383525008172
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!